PCVX vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 17, 2026

PCVX

55.3
AI Score
VS
PCVX Wins

BBIO

46.6
AI Score

Investment Advisor Scores

PCVX

55score
Recommendation
HOLD

BBIO

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PCVX BBIO Winner
Net Income -604.92M -732.94M PCVX
Operating Income -648.63M -523.41M BBIO
ROE -21.9% 35.1% BBIO
ROA -19.3% -78.3% PCVX
Total Assets 3.14B 936.02M PCVX
Cash 183.19M 570.12M BBIO
Current Ratio 5.72 2.77 PCVX
Free Cash Flow -519.52M -447.01M BBIO

Relative Price Performance (Last 90 Days)

PCVX 1M: -7.8% · 3M: -4.0% BBIO 1M: -12.6% · 3M: -13.3%

Current Technical Phase

PCVX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.9 · Price: $56.05

BBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 36

RSI (14): 36.5 · Price: $66.91

Fundamentals Snapshot

Metric PCVX BBIO
Market Cap — —
Forward P/E -7.8 2433.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 1.2%
Gross Margin — 0.9%
Operating Margin 0.0% -0.4%
EPS -7.63 -3.56
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PCVX is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.